| 摘要 |
<p>The invention relates to compounds of formula (I), where R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, M1, M2, M3, M4, Y1, Y2, V, W, n, m and o have the meanings specified herein, and to the physiologically compatible salts, derivatives, prodrugs, solvates, tautomers and stereoisomers thereof, including the mixtures thereof in all ratios, for use in the treatment of diseases that are influenced by inhibiting sphingosine kinase 1.</p> |
